Fast Brain MRI in Children With Suspected Brain Tumor
- Conditions
- DiagnosisBrain Neoplasms, ChildhoodImageMagnetic Resonance ImagingBrain NeoplasmsNeuroimagingBrain TumorPediatric
- Interventions
- Diagnostic Test: Fast MRI (Neuromix)
- Registration Number
- NCT05776602
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients
- Detailed Description
The study aims to assess the diagnostic performance of fast MR sequence for the radiological evaluation of brain tumor in comparison to routine clinical MRI (or reference standard) in a pediatric population.
The primary outcome is the depiction and characterization of normal brain, brain tumor pathology and incidental findings.
Sensitivity, specificity, AUC and intra-/ interreader agreement for the diagnostic performance of Neuromix compared to cMRI will be obtained. Correlation of results between methods will be calculated.
Secondary outcomes will also include the assessment of diagnostic image quality and image artifacts.
The study population will consist of subjects aged 0-18 with a suspected or diagnosed brain tumor referred for routine MRI examination of the brain.
Study subjects will be investigated during the same day at 3T MR with Neuromix sequence in addition to the routine MRI examination.
Volume measurements will be compared.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Age 0-18 years.
- Pediatric subjects with diagnosed or suspected brain tumor
- Referral routine MRI study.
- MRI planned without sedation
- Aborted MR exam
- Unstable patient
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pediatric patients with suspected or confirmed brain tumor Fast MRI (Neuromix) New method och standard MRI in clinical care
- Primary Outcome Measures
Name Time Method Diagnostic performance Through study completion, an average of 1 year AUC, area under the curve for the comparison of the new method against the reference standard
- Secondary Outcome Measures
Name Time Method Imaging quality through study completion, an average of 1 year Image quality on both methods
Agreement through study completion, an average of 1 year Agreement between readers and methods
Sensitivity through study completion, an average of 1 year Sensitivity of the new method against the reference standard
Imaging artifacts through study completion, an average of 1 year Image artifacts on both methods
Correlation through study completion, an average of 1 year Correlation between readers and methods
Specificity through study completion, an average of 1 year Specificity of the new method against the reference standard
Trial Locations
- Locations (1)
Karolinksa Universitetssjukhuset
🇸🇪Stockholm, Sweden